CMS Profit Halves to HKD1.24B Despite 5.5% Revenue Growth

Edgen Stock·Mar 26 2026, 16:51

Share to

Share to

Copy link

Key Takeaways

China Medical System Holdings (CMS) reported divergent 2025 annual results, with revenue growth overshadowed by a significant contraction in profitability. The company's net profit was nearly halved, leading to a substantial cut in its final dividend payout to shareholders.

Profit Collapse: Net profit plummeted by 49.7% year-over-year to HKD1.241 billion.
Divergent Growth: Revenue increased by 5.5% to HKD12.283 billion, while gross profit grew by only 0.6%.
Dividend Reduction: The final dividend was slashed to HKD0.169 per share, down from HKD0.26 in the prior year.

Net Profit Plunges 49.7% Despite Revenue Growth

China Medical System Holdings (CMS) announced its 2025 annual results, revealing a severe disconnect between its top-line growth and bottom-line profitability. While revenue for the year climbed 5.5% to HKD12.283 billion, net profit was nearly cut in half, falling 49.7% to HKD1.241 billion. This resulted in earnings per share of HKD0.3544.

The profit erosion suggests significant margin pressure or escalating operating expenses. Gross profit saw a marginal increase of just 0.6% to HKD6.78 billion, indicating that costs outpaced revenue growth and severely impacted the company's ability to convert sales into profit.

Dividend Slashed to HKD0.169 After Profit Contraction

In a direct response to the weakened earnings, CMS declared a final dividend of HKD0.169 per share. This represents a significant reduction from the HKD0.26 per share distributed in the same period last year.

The dividend cut signals a more conservative capital allocation strategy from management and will likely disappoint income-focused investors. The sharp decline in profitability and the corresponding reduction in shareholder returns are expected to trigger a negative market reaction and a re-evaluation of the company's financial health.